GeneReach Biotechnology Financial Flexibility Index
GeneReach Biotechnology financial flexibility index. GeneReach Biotechnology (4171) has a Financial Flexibility Index of 0.05x as of June 2026. Free cash flow of NT$14.41 Million (operating CF NT$6.28 Million minus capex NT$8.13 Million) represents 0% of total liabilities (NT$276.64 Million). See GeneReach Biotechnology free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GeneReach Biotechnology (2017–2025)
Financial flexibility index of GeneReach Biotechnology from 2017 to 2025. Historical Financial Flexibility Index trend for GeneReach Biotechnology across 9 annual periods. Check GeneReach Biotechnology (4171) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
GeneReach Biotechnology Financial Flexibility Index by Year (2017–2025)
GeneReach Biotechnology financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for GeneReach Biotechnology. For the full cash flow conversion analysis, see GeneReach Biotechnology cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | NT$-1.88 Million | NT$-13.52 Million | NT$284.34 Million | ▲ +84.7% |
| 2024 | -0.04x | NT$-14.76 Million | NT$-23.22 Million | NT$341.00 Million | ▼ -20.0% |
| 2023 | -0.04x | NT$-11.32 Million | NT$-38.67 Million | NT$313.71 Million | ▼ -104.7% |
| 2022 | 0.78x | NT$402.54 Million | NT$357.63 Million | NT$519.23 Million | ▲ +26.7% |
| 2021 | 0.61x | NT$364.78 Million | NT$348.99 Million | NT$596.35 Million | ▼ -0.2% |
| 2020 | 0.61x | NT$234.69 Million | NT$169.82 Million | NT$382.75 Million | ▲ +4297.5% |
| 2019 | 0.01x | NT$2.34 Million | NT$-11.19 Million | NT$167.82 Million | ▼ -33.7% |
| 2018 | 0.02x | NT$8.05 Million | NT$5.74 Million | NT$382.68 Million | ▲ +225.0% |
| 2017 | -0.02x | NT$-5.93 Million | NT$-6.83 Million | NT$352.21 Million | — |